3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Hepatocellular
2
Uterine Cervical Neoplasms
1
Triple Negative Breast Neoplasms
1
Pancreatic Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms
1
Interventions
pembrolizumab
11
enfortumab vedotin
7
Magnetic Resonance Spectroscopy
7
Specimen Handling
6
Nivolumab
6
Ipilimumab
4
sacituzumab govitecan
3
Gemcitabine
3
Docetaxel
3
CTLA-4 Antigen
3
zanidatamab
2
cabozantinib
2
atezolizumab
2
Taxes
2
Paclitaxel
2
Cisplatin
2
relatlimab
1
eribulin
1
avelumab
1
X-Rays
1
Single Person
1
Radiosurgery
1
Radiation Dose Hypofractionation
1
Platinum
1
Mitomycin
1
Injections
1
Fluorouracil
1
Cystectomy
1
Carboplatin
1
CA-4948
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Transitional Cell
×
camrelizumab
×
30 days
×
Clear all
No trials found.